Munafa Stock Market Course + Intraday & FNO calls 
Biocryst Pharmaceuticals (BCRX) Technical (Analysis) Reports Biocryst Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biocryst Pharmaceuticals (BCRX)
Technical Analysis Report for NASDAQ stock BCRX Biocryst Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BCRX Biocryst Pharmaceuticals then click here. or read Experts views on Biocryst Pharmaceuticals or Forecast & share price targets of Biocryst Pharmaceuticals
Biocryst Pharmaceuticals Opened at 6.43 and Closed at: 6.38, which is 2.19% of previous session's close. It moved within a range of 6.26 and 6.43
The session was a Bearish session with an average volume of 6346400, which is 28.83% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 6.24 and resistance for tomorrow is 6.41
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 6.28, 6.19 resistance for tomorrow's hourly charts is 6.45, 6.53
10 Day SMA for Biocryst Pharmaceuticals (BCRX) is 6.59 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Biocryst Pharmaceuticals (BCRX) is 6.73 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Biocryst Pharmaceuticals (BCRX) is 7.2 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 7.21 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Biocryst Pharmaceuticals is 8.18 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Biocryst Pharmaceuticals is at 6.73 and 200 DMA is at 8.18, while 50 DMA and 100 DMA are at 7.2 and 7.21 respectively
Biocryst Pharmaceuticals (BCRX) moving average of 20 SMA is at 6.73 and 20 EMA is at 6.75
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 6.38 | 6.73 | 6.75 |
| 05 Thu Feb | 6.24 | 6.8 | 6.79 |
| 04 Wed Feb | 6.42 | 6.88 | 6.85 |
| 03 Tue Feb | 6.71 | 6.94 | 6.9 |
| 02 Mon Feb | 6.63 | 6.97 | 6.92 |
| 30 Fri Jan | 6.58 | 7.02 | 6.95 |
Biocryst Pharmaceuticals (BCRX) moving average of 50 SMA is at 7.2 and 50 EMA is at 7.05
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 6.38 | 7.2 | 7.05 |
| 05 Thu Feb | 6.24 | 7.21 | 7.08 |
| 04 Wed Feb | 6.42 | 7.23 | 7.11 |
| 03 Tue Feb | 6.71 | 7.24 | 7.14 |
| 02 Mon Feb | 6.63 | 7.24 | 7.16 |
| 30 Fri Jan | 6.58 | 7.25 | 7.18 |
Biocryst Pharmaceuticals (BCRX) moving average of 100 SMA is at 7.21 and 100 EMA is at 7.31
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 6.38 | 7.21 | 7.31 |
| 05 Thu Feb | 6.24 | 7.22 | 7.33 |
| 04 Wed Feb | 6.42 | 7.24 | 7.35 |
| 03 Tue Feb | 6.71 | 7.26 | 7.37 |
| 02 Mon Feb | 6.63 | 7.27 | 7.38 |
| 30 Fri Jan | 6.58 | 7.28 | 7.4 |
Biocryst Pharmaceuticals (BCRX) moving average of 200 SMA is at 8.18 and 200 EMA is at 7.71
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 6.38 | 8.18 | 7.71 |
| 05 Thu Feb | 6.24 | 8.19 | 7.72 |
| 04 Wed Feb | 6.42 | 8.19 | 7.73 |
| 03 Tue Feb | 6.71 | 8.2 | 7.74 |
| 02 Mon Feb | 6.63 | 8.2 | 7.75 |
| 30 Fri Jan | 6.58 | 8.2 | 7.76 |
Biocryst Pharmaceuticals has performed better than Verastem Inc in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Biocryst Pharmaceuticals has performed better than Summit Therapeutics in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Repros Therapeutics has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Repros Therapeutics, about 24.93% more returns!
Petmed Express has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Petmed Express, about 0.53% more returns!
Ovid Therapeutics has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 9.59% more returns!
Biocryst Pharmaceuticals has performed better than Novocure in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Kezar Life has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Kezar Life, about 12.49% more returns!
Biocryst Pharmaceuticals has performed better than Kura Oncology in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Adma Biologics has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Adma Biologics, about 5.31% more returns!
Alector Inc has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Alector Inc, about 19.16% more returns!
Argenx Se has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Argenx Se, about 16.69% more returns!
Array Biopharma has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Array Biopharma, about 45.7% more returns!
Atricure Inc has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Atricure Inc, about 3.29% more returns!
Capricor Therapeutics has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 17.47% more returns!
Halozyme Therapeutics has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 25.87% more returns!
Biocryst Pharmaceuticals has performed better than Helius Medical in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Immutep has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Immutep, about 2.59% more returns!
Kalvista Pharmaceuticals has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 2.47% more returns!
Biocryst Pharmaceuticals Technical analysis of indicators
Price action analysis of Biocryst Pharmaceuticals (BCRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biocryst Pharmaceuticals in short term and the sell signal is strong.
Biocryst Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biocryst Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Biocryst Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.57 and Biocryst Pharmaceuticals BCRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biocryst Pharmaceuticals BCRX stock. Volume based technical analysis of Biocryst Pharmaceuticals BCRX stock is negative.
Biocryst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock BCRX Biocryst Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BCRX Experts View which covers a lot of information including buying and selling signals
BCRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biocryst Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biocryst Pharmaceuticals (BCRX) Technical (Analysis) Reports Biocryst Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
